Eli Lilly and Co., Lilly Corporate Center, Indianapolis, 46285 (www.lilly.com) discovers, develops, manufactures and sells pharmaceutical products for humans and animals. The company reported 2013 net income of $4.7 billion, or $4.32 per diluted share, on revenue of $23.1 billion. That compares with 2012 net income of $4.1 billion, or $3.66 per diluted share, on $22.6 billion in revenue. The company’s shares trade on the New York Stock Exchange under the ticker symbol LLY. Information for Proxy Corner was taken from Yahoo Finance and from the company’s proxy statement dated March 24, 2014. View full Proxy Corner feature.
Please enable JavaScript to view this content.